Advanced
  Home Compare Reports

Comparison with Similar Reports

Enteral Feeding Devices Market by Type (Feeding Tube (Gastrostomy, Jejunostomy), Feeding Pump, Giving Set), Age Group (Adult, Pediatric), Application ...

Publisher:        MarketsandMarkets

# of Pages:        373

Rating: 

1 User License $4,950

Publication Date:  November, 2021

Price:       $4,950 / User License




1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.3.3 CURRENCY 51
1.3.4 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 51
1.4 STAKEHOLDERS 52
1.5 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
FIGURE 1 RESEARCH DESIGN 53
2.1.1 SECONDARY DATA 53
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
FIGURE 2 PRIMARY SOURCES 55
2.1.2.1 Key data from primary sources 56
2.1.2.2 Key industry insights 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 57
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 58
2.2 MARKET SIZE ESTIMATION 58
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 59
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: NESTLÉ S.A. 59
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: ENTERAL FEEDING DEVICES MARKET (2020) 60
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ENTERAL FEEDING DEVICES MARKET (2021–2026) 62
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 62
FIGURE 10 TOP-DOWN APPROACH 63
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 64
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 64
2.4 MARKET SHARE ANALYSIS 64
2.5 ASSUMPTIONS FOR THE STUDY 65
2.6 RISK ASSESSMENT 65
TABLE 1 RISK ASSESSMENT: ENTERAL FEEDING DEVICES MARKET 65
2.7 LIMITATIONS 66
2.7.1 METHODOLOGY-RELATED LIMITATIONS 66
2.7.2 SCOPE-RELATED LIMITATIONS 66
3 EXECUTIVE SUMMARY 67
FIGURE 12 ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 13 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2021 VS. 2026 (USD MILLION) 68
FIGURE 14 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 69
FIGURE 15 ENTERAL FEEDING DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 69
FIGURE 16 GEOGRAPHIC ANALYSIS: GLOBAL ENTERAL FEEDING DEVICES MARKET 70
4 PREMIUM INSIGHTS 72
4.1 ENTERAL FEEDING DEVICES MARKET OVERVIEW 72
FIGURE 17 INCREASING PREVALENCE OF CHRONIC DISEASES AND SHIFT FROM PARENTERAL NUTRITION TO ENTERAL NUTRITION TO DRIVE MARKET GROWTH 72
4.2 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY TYPE 73
FIGURE 18 ENTERAL FEEDING TUBES ACCOUNTED FOR THE LARGEST SHARE OF
THE APAC ENTERAL FEEDING DEVICES MARKET IN 2020 73
4.3 ENTERAL FEEDING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
FIGURE 19 MARKET IN CHINA TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 74
4.4 ENTERAL FEEDING DEVICES MARKET, BY REGION 75
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ENTERAL FEEDING DEVICES MARKET TILL 2026 75
4.5 ENTERAL FEEDING DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 75
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN
THE FORECAST PERIOD 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 22 ENTERAL FEEDING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
5.2.1 DRIVERS 77
5.2.1.1 Shift from parenteral to enteral nutrition 77
5.2.1.2 Increasing incidence of preterm births 77
FIGURE 23 TOTAL NUMBER OF PRETERM BIRTHS IN THE US, 2010–2019 78
5.2.1.3 Growing demand for enteral feeding in the home care sector 78
5.2.1.4 Rapid growth in the geriatric population and subsequent growth in the prevalence of chronic diseases 79
FIGURE 24 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 79
FIGURE 25 GLOBAL CANCER INCIDENCE, 2015–2040 80
FIGURE 26 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION INDIVIDUALS) 81
5.2.1.5 Increasing prevalence of dysphagia 81
5.2.2 RESTRAINTS 82
5.2.2.1 Complications associated with enteral feeding devices 82
TABLE 2 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING 82
5.2.3 OPPORTUNITIES 84
5.2.3.1 High growth opportunities in emerging countries 84
5.2.4 CHALLENGES 85
5.2.4.1 Insufficient reimbursements for enteral nutrition 85
5.2.4.2 Dearth of skilled professionals 85
6 INDUSTRY INSIGHTS 87
6.1 INTRODUCTION 87
6.2 INDUSTRY TRENDS 87
6.2.1 GROWING PREFERENCE FOR LOW-PROFILE TUBES 87
6.2.2 SHIFT OF HEALTHCARE PROVISION FROM HOSPITAL TO COMMUNITY SETTINGS 87
6.3 REGULATORY LANDSCAPE 88
6.4 REIMBURSEMENT SCENARIO 89
6.5 VALUE CHAIN ANALYSIS 90
FIGURE 27 ENTERAL FEEDING DEVICES MARKET: VALUE CHAIN ANALYSIS 91
6.6 SUPPLY CHAIN ANALYSIS 91
FIGURE 28 ENTERAL FEEDING DEVICES MARKET: SUPPLY CHAIN ANALYSIS 92
6.7 PRICING ANALYSIS 93
TABLE 3 AVERAGE PRICE OF ENTERAL FEEDING DEVICES, BY REGION 93
6.8 IMPACT OF COVID-19 ON THE ENTERAL FEEDING DEVICES MARKET 93
6.9 ECOSYSTEM MARKET MAP 94
FIGURE 29 ENTERAL FEEDING DEVICES MARKET: ECOSYSTEM MARKET MAP 95
6.10 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 95
6.10.1 THREAT FROM NEW ENTRANTS 96
6.10.2 THREAT FROM SUBSTITUTES 96
6.10.3 BARGAINING POWER OF SUPPLIERS 97
6.10.4 BARGAINING POWER OF BUYERS 97
6.10.5 COMPETITIVE RIVALRY 97
6.11 PATENT ANALYSIS 97
6.11.1 PATENT PUBLICATION TRENDS FOR ENTERAL FEEDING DEVICES 97
FIGURE 30 PATENT PUBLICATION TRENDS (2011–OCTOBER 2021) 98
6.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 98
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERAL FEEDING DEVICE PATENTS (JANUARY 2011–OCTOBER 2021) 99
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR ENTERAL FEEDING DEVICE PATENTS (JANUARY 2011–OCTOBER 2021) 100
6.12 TECHNOLOGY ANALYSIS 100
6.12.1 KEY TECHNOLOGIES 100
6.12.1.1 Flow generation 100
6.12.1.2 Flow control 100
6.12.2 COMPLEMENTARY TECHNOLOGIES 101
6.12.2.1 Embedded software 101
6.12.2.2 Sensing technology 101
6.12.2.3 Feeding tube replacement technology 101
6.12.2.3.1 Electromagnetic sensor-based systems 101
6.12.2.3.2 Camera-based systems 102
6.12.2.3.3 Impedance sensor-based systems 102
6.12.3 ADJACENT TECHNOLOGIES 102
6.12.3.1 Nutritional formula development 102
6.12.3.2 Wireless connectivity 103
6.12.3.3 Model-based infusion pumps 103
7 ENTERAL FEEDING DEVICES MARKET, BY TYPE 104
7.1 INTRODUCTION 105
7.2 COVID-19 IMPACT ON THE ENTERAL FEEDING DEVICES MARKET, BY TYPE 105
TABLE 5 ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 6 ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 106
7.3 ENTERAL FEEDING TUBES 106
TABLE 7 MAJOR BRANDS OF ENTERAL FEEDING TUBES AVAILABLE IN THE MARKET 107
TABLE 8 ENTERAL FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 9 ENTERAL FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
7.3.1 ENTEROSTOMY FEEDING TUBES 109
TABLE 10 MAJOR BRANDS OF ENTEROSTOMY FEEDING TUBES AVAILABLE IN
THE MARKET 109
TABLE 11 ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 12 ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 111
TABLE 13 ENTEROSTOMY FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 14 ENTEROSTOMY FEEDING TUBES MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 112
7.3.1.1 Standard tubes 113
TABLE 15 STANDARD TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 16 STANDARD TUBES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 17 STANDARD TUBES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 114
7.3.1.1.1 Standard gastrostomy tubes 115
7.3.1.1.1.1 Increasing incidence of neurological disorders to drive the adoption of standard gastrostomy tubes 115
TABLE 18 STANDARD GASTROSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 116
7.3.1.1.2 Standard jejunostomy tubes 116
7.3.1.1.2.1 Minimally invasive nature of these tubes is driving their adoption in home care settings 116
TABLE 19 STANDARD JEJUNOSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
7.3.1.1.3 Standard gastrojejunostomy tubes 118
7.3.1.1.3.1 GJ tubes are adopted by patients with poor stomach function or motility 118
TABLE 20 STANDARD GASTROJEJUNOSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
7.3.1.2 Low-profile tubes 119
TABLE 21 LOW-PROFILE TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 120
TABLE 22 LOW-PROFILE TUBES MARKET, BY REGION, 2019–2026 (USD MILLION) 120
TABLE 23 LOW-PROFILE TUBES MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 121
7.3.1.2.1 Low-profile gastrostomy tubes 121
7.3.1.2.1.1 Low-profile gastrostomy tubes are expected to dominate the low-profile tubes market during the forecast period 121
TABLE 24 LOW-PROFILE GASTROSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
7.3.1.2.2 Low-profile jejunostomy tubes 123
7.3.1.2.2.1 Growing demand for these tubes in hospitals and ambulatory care settings to drive market growth 123
TABLE 25 LOW-PROFILE JEJUNOSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
7.3.1.2.3 Low-profile gastrojejunostomy tubes 124
7.3.1.2.3.1 Increasing demand for button gastrojejunostomy tubes to drive market growth 124
TABLE 26 LOW-PROFILE GASTROJEJUNOSTOMY TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.3.2 NASOENTERIC FEEDING TUBES 125
TABLE 27 MAJOR BRANDS OF NASOENTERIC FEEDING TUBES AVAILABLE IN
THE MARKET 125
TABLE 28 NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 29 NASOENTERIC FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
TABLE 30 NASOENTERIC FEEDING TUBES MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 127
7.3.2.1 Nasogastric feeding tubes 127
7.3.2.1.1 Short-term feeding is a major application of these tubes 127
TABLE 31 NASOGASTRIC FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.3.2.2 Nasojejunal feeding tubes 128
7.3.2.2.1 Double-lumen tubes are used for critically ill and postoperative patients and are witnessing wide adoption
in hospitals 128
TABLE 32 NASOJEJUNAL FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.3.2.3 Nasoduodenal feeding tubes 130
7.3.2.3.1 High adoption of these tubes in hospitals and clinics to drive the growth of this segment in the coming years 130
TABLE 33 NASODUODENAL FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 130
7.3.3 OROENTERIC FEEDING TUBES 131
7.3.3.1 Oroenteric tubes are mostly used for feeding preterm babies as they have a lower potential risk of breathing complications 131
TABLE 34 OROENTERIC FEEDING TUBES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
7.4 ENTERAL FEEDING PUMPS 132
7.4.1 ENHANCEMENTS IN PUMP DESIGNS AND GROWTH IN THE HOME HEALTHCARE MARKET ARE DRIVING THE ADOPTION OF ENTERAL FEEDING PUMPS 132
TABLE 35 MAJOR BRANDS OF ENTERAL FEEDING PUMPS AVAILABLE IN THE MARKET 132
TABLE 36 ENTERAL FEEDING PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
TABLE 37 ENTERAL FEEDING PUMPS MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 134
7.5 ADMINISTRATION SETS 134
7.5.1 INCREASING FOCUS ON PATIENT CARE AND PRODUCT SAFETY HAS LED TO THE INTRODUCTION OF ENFIT CONNECTORS—A KEY FACTOR DRIVING MARKET GROWTH 134
TABLE 38 MAJOR BRANDS OF ADMINISTRATION SETS AVAILABLE IN THE MARKET 135
TABLE 39 ENTERAL FEEDING ADMINISTRATION SETS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
TABLE 40 ENTERAL FEEDING ADMINISTRATION SETS MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 137
7.6 ENTERAL SYRINGES 137
7.6.1 OVER HALF A MILLION ADULTS AND CHILDREN RELY ON TUBE FEEDING IN THE US ALONE, OWING TO WHICH THE DEMAND FOR ENTERAL SYRINGES IS EXPECTED TO INCREASE IN THE COMING YEARS 137
TABLE 41 MAJOR BRANDS OF ENTERAL SYRINGES AVAILABLE IN THE MARKET 138
TABLE 42 ENTERAL SYRINGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 43 ENTERAL SYRINGES MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 139
7.7 CONSUMABLES 140
TABLE 44 MAJOR BRANDS OF CONSUMABLES AVAILABLE IN THE MARKET 140
TABLE 45 ENTERAL FEEDING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
 
8 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP 142
8.1 INTRODUCTION 143
TABLE 46 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 143
8.2 ADULT PATIENTS 143
8.2.1 HIGH BURDEN OF CHRONIC DISEASES AMONG ADULTS TO DRIVE GROWTH IN THIS MARKET SEGMENT 143
TABLE 47 ENTERAL FEEDING DEVICES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2019–2026 (USD MILLION) 144
8.3 PEDIATRIC PATIENTS 145
8.3.1 INCREASING NUMBER OF PRETERM BIRTHS—A MAJOR FACTOR DRIVING
THE GROWTH OF THE MARKET FOR PEDIATRIC PATIENTS 145
TABLE 48 ENTERAL FEEDING DEVICES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2019–2026 (USD MILLION) 146
9 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION 147
9.1 INTRODUCTION 148
TABLE 49 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 148
9.2 ONCOLOGY 148
FIGURE 33 NUMBER OF NEW CANCER CASES, BY REGION (2020) 149
TABLE 50 ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 51 ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY COUNTRY,
2019–2026 (USD MILLION) 150
9.2.1 HEAD & NECK CANCERS 150
9.2.1.1 10% of people who survive head & neck cancers require permanent enteral feeding because of dysphagia 150
TABLE 52 ESTIMATED NUMBER OF NEW CASES OF HEAD & NECK CANCERS,
BY REGION (2020–2040) 151
TABLE 53 ENTERAL FEEDING DEVICES MARKET FOR HEAD & NECK CANCERS,
BY COUNTRY, 2019–2026 (USD MILLION) 152
9.2.2 STOMACH & GASTROINTESTINAL CANCERS 152
9.2.2.1 High burden of stomach & GI cancers to support market growth 152
TABLE 54 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040) 153
TABLE 55 ENTERAL FEEDING DEVICES MARKET FOR STOMACH & GASTROINTESTINAL CANCERS, BY COUNTRY, 2019–2026 (USD MILLION) 153
9.2.3 LIVER CANCER 154
9.2.3.1 Patients with liver cancer are more likely to accept nasogastric tube placement 154
TABLE 56 ESTIMATED NUMBER OF NEW CASES OF LIVER CANCER, BY REGION
(2020–2040) 154
TABLE 57 ENTERAL FEEDING DEVICES MARKET FOR LIVER CANCER, BY COUNTRY, 2019–2026 (USD MILLION) 155
9.2.4 PANCREATIC CANCER 155
9.2.4.1 Nutrition supplementation plays an integral role in pancreatic cancer surgery 155
TABLE 58 ESTIMATED NUMBER OF NEW CASES OF PANCREATIC CANCER, BY REGION (2020–2040) 156
TABLE 59 ENTERAL FEEDING DEVICES MARKET FOR PANCREATIC CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 157
9.2.5 ESOPHAGEAL CANCER 157
9.2.5.1 Growing prevalence of esophageal cancer to support market growth 157
TABLE 60 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040) 158
TABLE 61 ENTERAL FEEDING DEVICES MARKET FOR ESOPHAGEAL CANCER,
BY COUNTRY, 2019–2026 (USD MILLION) 158
9.2.6 OTHER CANCERS 159
TABLE 62 ESTIMATED NUMBER OF NEW CASES OF OTHER CANCERS, BY REGION (2020–2040) 159
TABLE 63 ENTERAL FEEDING DEVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION) 160
9.3 GASTROINTESTINAL DISEASES 161
9.3.1 INCREASING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE
THE ADOPTION OF ENTERAL FEEDING DEVICES 161
TABLE 64 DISEASES & DISORDERS OF THE DIGESTIVE SYSTEM 161
TABLE 65 ENTERAL FEEDING DEVICES MARKET FOR GASTROINTESTINAL DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 162
9.4 NEUROLOGICAL DISORDERS 162
9.4.1 HIGH BURDEN OF NEUROLOGICAL DISORDERS TO FUEL THE DEMAND FOR CLINICAL NUTRITION THERAPIES 162
TABLE 66 ENTERAL FEEDING DEVICES MARKET FOR NEUROLOGICAL DISORDERS,
BY COUNTRY, 2019–2026 (USD MILLION) 164
9.5 DIABETES 164
9.5.1 USE OF ENTERAL FEEDING SYSTEMS IN DIABETICS HELPS PREVENT HYPERGLYCEMIA AND ASSOCIATED COMPLICATIONS 164
FIGURE 34 TOTAL NUMBER OF NEW DIABETES CASES, BY COUNTRY, 2020 165
TABLE 67 ENTERAL FEEDING DEVICES MARKET FOR DIABETES, BY COUNTRY,
2019–2026 (USD MILLION) 166
9.6 HYPERMETABOLISM 166
9.6.1 ENTERAL NUTRITION IS THE MOST WIDELY ACCEPTED THERAPY FOR MANAGING HYPERMETABOLISM 166
TABLE 68 ENTERAL FEEDING DEVICES MARKET FOR HYPERMETABOLISM, BY COUNTRY, 2019–2026 (USD MILLION) 167
9.7 OTHER APPLICATIONS 168
TABLE 69 ENTERAL FEEDING DEVICES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 169
 
10 ENTERAL FEEDING DEVICES MARKET, BY END USER 170
10.1 INTRODUCTION 171
10.2 COVID-19 IMPACT ON THE ENTERAL FEEDING DEVICES MARKET, BY END USER 171
TABLE 70 ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 171
10.3 HOSPITALS 172
10.3.1 HOSPITALS ARE THE LARGEST END USERS OF ENTERAL FEEDING DEVICES 172
TABLE 71 ENTERAL FEEDING DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 173
TABLE 72 ENTERAL FEEDING TUBES MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 73 ADMINISTRATION SETS MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 74 ENTERAL FEEDING PUMPS MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 176
TABLE 75 ENTERAL SYRINGES MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 177
10.4 HOME CARE SETTINGS 177
10.4.1 INCREASING NEED TO CURTAIL HOSPITAL COSTS IS SUPPORTING
THE GROWTH OF THE HOME CARE SETTINGS SEGMENT 177
TABLE 76 ENTERAL FEEDING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 178
TABLE 77 ENTERAL FEEDING TUBES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 179
TABLE 78 ADMINISTRATION SETS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 180
TABLE 79 ENTERAL FEEDING PUMPS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 181
TABLE 80 ENTERAL SYRINGES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 182
10.5 AMBULATORY CARE SETTINGS 182
10.5.1 SHORTAGE OF NURSING STAFF IN AMBULATORY CARE SETTINGS TO HAMPER MARKET GROWTH 182
TABLE 81 ENTERAL FEEDING DEVICES MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 183
TABLE 82 ENTERAL FEEDING TUBES MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 184
TABLE 83 ADMINISTRATION SETS MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 185
TABLE 84 ENTERAL FEEDING PUMPS MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 186
TABLE 85 ENTERAL SYRINGES MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 187
 
11 ENTERAL FEEDING DEVICES MARKET, BY REGION 188
11.1 INTRODUCTION 189
11.2 COVID-19 IMPACT ON THE ENTERAL FEEDING DEVICES MARKET, BY REGION 189
FIGURE 35 ENTERAL FEEDING DEVICES MARKET: GEOGRAPHIC SNAPSHOT 190
TABLE 86 ENTERAL FEEDING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 190
11.3 NORTH AMERICA 191
FIGURE 36 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 192
TABLE 87 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 192
TABLE 88 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 89 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 193
TABLE 90 NORTH AMERICA: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 91 NORTH AMERICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 92 NORTH AMERICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 194
TABLE 93 NORTH AMERICA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 94 NORTH AMERICA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 95 NORTH AMERICA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 96 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 196
TABLE 97 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 196
TABLE 98 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 99 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 197
11.3.1 US 198
11.3.1.1 Presence of major manufacturers and providers of enteral feeding devices and the availability of technologically advanced products to drive growth in the US market 198
TABLE 100 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN THE US 199
TABLE 101 US: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 102 US: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 103 US: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 104 US: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 105 US: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 106 US: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 107 US: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 201
TABLE 108 US: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 201
TABLE 109 US: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 110 US: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 202
11.3.2 CANADA 202
11.3.2.1 Increasing incidence of chronic diseases such as diabetes and cancer is supporting market growth in the country 202
TABLE 111 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET
IN CANADA 203
TABLE 112 CANADA: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 113 CANADA: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 114 CANADA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 115 CANADA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 116 CANADA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 117 CANADA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 118 CANADA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 206
TABLE 119 CANADA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 206
TABLE 120 CANADA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 121 CANADA: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 207
11.4 EUROPE 208
TABLE 122 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 208
TABLE 123 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 124 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 209
TABLE 125 EUROPE: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 126 EUROPE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 127 EUROPE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (THOUSAND UNITS) 210
TABLE 128 EUROPE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 129 EUROPE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 130 EUROPE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 211
TABLE 131 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 211
TABLE 132 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 212
TABLE 133 EUROPE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 134 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 213
11.4.1 GERMANY 213
11.4.1.1 Germany holds the largest share of the European enteral feeding devices market 213
TABLE 135 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN GERMANY 214
TABLE 136 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 137 GERMANY: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 138 GERMANY: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 139 GERMANY: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 140 GERMANY: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 141 GERMANY: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 142 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 216
TABLE 143 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 216
TABLE 144 GERMANY: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 145 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 217
11.4.2 UK 217
11.4.2.1 The UK has seen a significant increase in the prevalence of cancer and neurological disorders, which will aid market growth 217
TABLE 146 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN THE UK 218
TABLE 147 UK: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 148 UK: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 149 UK: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 150 UK: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 151 UK: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 152 UK: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 153 UK: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 221
TABLE 154 UK: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 221
TABLE 155 UK: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 156 UK: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 222
11.4.3 FRANCE 222
11.4.3.1 The market in France is supported by the country’s well-established healthcare system 222
TABLE 157 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN FRANCE 223
TABLE 158 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 159 FRANCE: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 160 FRANCE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 161 FRANCE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 162 FRANCE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 163 FRANCE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 225
TABLE 164 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 225
TABLE 165 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 226
TABLE 166 FRANCE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 167 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 227
11.4.4 ITALY 227
11.4.4.1 Market growth is driven by the growing demand for cost-effective home care services in the country 227
TABLE 168 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN ITALY 228
TABLE 169 ITALY: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 170 ITALY: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 171 ITALY: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 172 ITALY: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 173 ITALY: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 174 ITALY: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 175 ITALY: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 230
TABLE 176 ITALY: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 230
TABLE 177 ITALY: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 178 ITALY: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 231
11.4.5 SWITZERLAND 231
11.4.5.1 The country’s well-developed medical technology industry is expected to support market growth 231
TABLE 179 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN SWITZERLAND 232
TABLE 180 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 181 SWITZERLAND: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 182 SWITZERLAND: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 183 SWITZERLAND: STANDARD ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 184 SWITZERLAND: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 185 SWITZERLAND: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 186 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 234
TABLE 187 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 235
TABLE 188 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 189 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 236
11.4.6 SPAIN 236
11.4.6.1 Significant increase in patients opting for enteral nutrition is expected to support market growth 236
TABLE 190 MACROINDICATORS FOR THE ENTERAL FEEDING DEVICES MARKET IN SPAIN 237
TABLE 191 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 192 SPAIN: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 193 SPAIN: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 238
TABLE 194 SPAIN: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 238
TABLE 195 SPAIN: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 238
TABLE 196 SPAIN: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 239
TABLE 197 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 239
TABLE 198 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 239
TABLE 199 SPAIN: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 200 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 240
11.4.7 BENELUX 240
11.4.7.1 Rising cases of cancer in this region to drive market growth in the coming years 240
TABLE 201 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 241
TABLE 202 BENELUX: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 203 BENELUX: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 204 BENELUX: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 242
TABLE 205 BENELUX: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 243
TABLE 206 BENELUX: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 243
TABLE 207 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2019–2026 (USD MILLION) 243
TABLE 208 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 244
TABLE 209 BENELUX: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2019–2026 (USD MILLION) 244
TABLE 210 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 245
11.4.8 REST OF EUROPE 245
TABLE 211 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 212 REST OF EUROPE: ENTERAL FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 213 REST OF EUROPE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 214 REST OF EUROPE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 215 REST OF EUROPE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 216 REST OF EUROPE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 217 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2019–2026 (USD MILLION) 248
TABLE 218 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 248
TABLE 219 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 220 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 249

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127